Johnson & Johnson (JNJ)
267.08
-2.04 (-0.76%)
NYSE· Last Trade: Sep 9th, 5:39 PM EDT
Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for the 2022 through 2027 period, citing a portfolio shift toward cardiovascular products, operating-m
Via MarketBeat · September 9, 2026
Stay informed with the top movers within the dow jones index on Wednesday.chartmill.com
Via Chartmill · September 9, 2026
These two are on the Dividend Kings list.
Via The Motley Fool · September 9, 2026
Stay informed with the top movers within the dow jones index on Tuesday.chartmill.com
Via Chartmill · September 8, 2026
Low-cost index funds can be a ticket to prosperity for everyday investors.
Via The Motley Fool · September 8, 2026
What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · September 8, 2026
Ahead of CPI data and the Fed's rate decision, defensive stocks McDonald's, Johnson & Johnson, Walmart, Berkshire Hathaway, and NextEra Energy offer stability and dividends amid market uncertainty.
Via MarketBeat · September 8, 2026
If interest rates rise, writing a prescription today for the State Street Health Care Select Sector SPDR ETF is a smart idea.
Via The Motley Fool · September 7, 2026
Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold.
Via The Motley Fool · September 5, 2026
Discover which dow jones stocks are making waves on Wednesday.chartmill.com
Via Chartmill · September 2, 2026
Which dow jones stocks are moving on Wednesday?chartmill.com
Via Chartmill · September 2, 2026
Stay informed with the top movers within the dow jones index on Tuesday.chartmill.com
Via Chartmill · September 1, 2026
These dow jones stocks are moving in today's sessionchartmill.com
Via Chartmill · September 1, 2026
One of J&J's investments stands head-and-shoulders above the rest.
Via The Motley Fool · August 31, 2026
AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.
Via The Motley Fool · August 29, 2026
Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.
Via The Motley Fool · August 28, 2026
Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs.
Via The Motley Fool · August 27, 2026
Thursday's session: top gainers and losers in the dow jones indexchartmill.com
Via Chartmill · August 27, 2026
Exploring the top movers within the dow jones index during today's session.chartmill.com
Via Chartmill · August 27, 2026
The company's autoimmune drug was approved for the treatment of a rare blood disease.
Via The Motley Fool · August 27, 2026
The company is firing on all cylinders.
Via The Motley Fool · August 26, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · August 26, 2026
These dow jones stocks are moving in today's sessionchartmill.com
Via Chartmill · August 25, 2026
Top dow jones movers in Tuesday's sessionchartmill.com
Via Chartmill · August 25, 2026
Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth.
Via Benzinga · August 25, 2026